Third Point’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

Third Point’s Portfolio MSACW Stock Details MSACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-87,774	Closed	-$62K	–	122
2021 Q3	$62K	Hold	87,774	–	–	﹤0.01%	113
2021 Q2	$89K	Buy	+87,774	New	+$69.5K	﹤0.01%	126

Other funds holding MSACW

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Third Point's MSACW Position: Q4 2021 in Review

Third Point sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q4 2021, closing a stake of 87,774 shares — an estimated $62K sold.

Third Point first reported a position in MSACW in Q2 2021 and held it in 2 quarters. The position peaked at $89K in Q2 2021. 16 funds tracked by Wall St. Rank hold MSACW as of Q4 2021.

Third Point reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q4 2021 after selling out during the quarter.
Third Point sold 87,774 Medicus Sciences Acquisition Corp. Warrant shares in Q4 2021, an estimated $62K.
Third Point first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q2 2021 and held it in 2 quarters.
Third Point's Medicus Sciences Acquisition Corp. Warrant position peaked at $89K in Q2 2021.
16 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q4 2021.

Based on Third Point's 13F filing for Q4 2021, filed 14 Feb 2022.